David’s unique and globally recognised 30-year career in pharmaceuticals has included over 24 years in senior global and regional roles. Committed to making a greater impact and passing on his leadership expertise, he joined Avril in a business partnership in 2019, and became CEO of AHAA! David is renowned for being the only Australian to have founded two multinational pharmaceutical companies in Australia and Asia Pacific (Actelion and Alexion). He and his teams, blazed a trail creating a whole new industry sector in these regions with life-saving and transforming products for ultra-rare diseases. As a leader who desires to make a difference, David was able to lead the creation of two of the most diverse workplaces in the pharmaceutical industry. In both companies, his senior leadership teams included over 80% females, as well as 80% of all staff made up of working parents with access to totally flexible workplace practices. Under David’s inclusive leadership, Actelion and Alexion broke numerous industry records, whilst at the same time also saving thousands of lives. David’s educational background spans registered nursing and postgraduate qualifications in critical care, marketing, business management, leadership and coaching, which he is now deploying to expand the services and influence of AHAA!